Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 1719 News Items found MSK Partners with Nassau County to Equitably Distribute COVID-19 Vaccines Wednesday, March 10, 2021 In partnership with the Nassau County Department of Health, MSK Nassau will help equitably distribute COVID-19 vaccinations. The National Cancer Act @ 50: The First "Cancer Centers" Monday, March 8, 2021 This year, MSK joins the National Cancer Institute and the larger cancer community in commemorating the 50th anniversary of the signing of the National Cancer Act of 1971. Women Leaders at MSK: Mini Kamboj Monday, March 8, 2021 Mini Kamboj says encouragement from her family during her early years help mold her into the strong, self-possessed leader needed to guide MSK through the COVID-19 pandemic. ‘Aren’t I Too Young?’ How MSK Helps People under 50 with Colorectal and GI Cancers Monday, March 8, 2021 Learn more about the first facility in the world devoted to the specific needs of colorectal cancer patients under the age of 50. Researchers Report Excellent Outcomes for New Leukemia and Lymphoma Drug Friday, March 5, 2021 The first-ever clinical trial of a new kind of drug, called pirtobrutinib or LOXO-305, has shown promising results in a phase I/II study. Feature In Memoriam: Developmental Biologist Kathryn V. Anderson Monday, March 1, 2021 Remembering Kathryn Anderson, the founding chair of the Developmental Biology Program in the Sloan Kettering Institute. MSK a Founding Member of Break Through Cancer Thursday, February 25, 2021 MSK is a founding member of Break Through Cancer, a newly launched foundation aimed at accelerating collaborative research, clinical trials, and cures for the deadliest cancers. In the Lab Clearing the Fog around Tumor Mutational Burden Monday, February 22, 2021 MSK researchers shed light on how the number of mutations in a tumor affect a patient’s response to immunotherapy drugs. Carol Brown, MD, Named a Notable Black Executive by Crain’s Monday, February 15, 2021 Gynecologic cancer surgeon Carol Brown featured in Crain's New York Business’ Notable Black Leaders and Executives list. Making Progress in Genitourinary Cancers: MSK Physicians Share Research Advances at Annual ASCO GU Symposium Monday, February 15, 2021 MSK's Robert Motzer presented positive data from a phase III randomized study that assessed two different treatment combinations as first-line therapies that may benefit people with advanced kidney cancer. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer